首页> 美国卫生研究院文献>Cold Spring Harbor Molecular Case Studies >Exome sequencing reveals germline gain-of-function EGFR mutation in an adult with Lhermitte–Duclos disease
【2h】

Exome sequencing reveals germline gain-of-function EGFR mutation in an adult with Lhermitte–Duclos disease

机译:外显子组测序显示成年人Lhermitte–Duclos病种系功能获得性EGFR突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lhermitte–Duclos disease (LDD) is a rare cerebellar disorder believed to be pathognomonic for Cowden syndrome. Presently, the only known etiology is germline PTEN mutation. We report a 41-yr-old white female diagnosed with LDD and wild-type for PTEN. Exome sequencing revealed a germline heterozygous EGFR mutation that breaks a disulfide bond in the receptor's extracellular domain, resulting in constitutive activation. Functional studies demonstrate activation of ERK/AKT signaling pathways, mimicking PTEN loss-of-function downstream effects. The identification of EGFR as a candidate LDD susceptibility gene contributes to advancement of molecular diagnosis and targeted therapy for this rare condition with limited treatment options.
机译:Lhermitte-Duclos病(LDD)是一种罕见的小脑疾病,被认为是Cowden综合征的病原。目前,唯一已知的病因是种系PTEN突变。我们报告了一名41岁的白人女性,诊断为LTEN和PTEN的野生型。外显子组测序显示种系杂合的EGFR突变会破坏受体胞外域中的二硫键,从而导致组成型激活。功能研究表明ERK / AKT信号通路的激活,模仿了PTEN功能丧失的下游效应。将EGFR鉴定为候选LDD易感基因有助于针对这种罕见病,治疗选择有限的分子诊断和靶向治疗的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号